Icds Ltd vs Indrayani Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 21, 2026

Key Highlights

The Latest Trading Price of ICDS Ltd is ₹ 46.91 as of 17 Apr 15:30 . The P/E Ratio of ICDS Ltd changed from 8.9 on March 2022 to 39.7 on March 2025 . This represents a CAGR of 45.33% over 4 yearsThe P/E Ratio of Indrayani Biotech Ltd changed from 23.5 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of ICDS Ltd changed from ₹ 52.11 crore on March 2022 to ₹ 55.91 crore on March 2025 . This represents a CAGR of 1.78% over 4 yearsThe Market Cap of Indrayani Biotech Ltd changed from ₹ 21.73 crore on March 2021 to ₹ 64.93 crore on March 2025 . This represents a CAGR of 24.47% over 5 years The revenue of ICDS Ltd for the Dec '25 is ₹ 0.96 crore as compare to the Sep '25 revenue of ₹ 0.36 crore. This represent the growth of 166.67% The revenue of Indrayani Biotech Ltd for the Dec '25 is ₹ 35.85 crore as compare to the Sep '25 revenue of ₹ 37.75 crore. This represent the decline of -5.03% The ebitda of ICDS Ltd for the Dec '25 is ₹ 0.64 crore as compare to the Sep '25 ebitda of ₹ -0.08 crore. This represent the decline of -900% The ebitda of Indrayani Biotech Ltd for the Dec '25 is ₹ 3.62 crore as compare to the Sep '25 ebitda of ₹ 4.25 crore. This represent the decline of -14.82% The net profit of ICDS Ltd changed from ₹ 0.69 crore to ₹ 0.46 crore over 7 quarters. This represents a CAGR of -20.68% The net profit of Indrayani Biotech Ltd changed from ₹ 0.85 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of -67.33% The Dividend Payout of ICDS Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Indrayani Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About ICDS Ltd

ICDS Limited was incorporated in October, 1971 and was registered as a Non-Banking Financial Company (NBFC).
The Company is presently concentrating on the recovery of its dues and repaying its liabilities and is also engaged in trading activities of shares and securities, mobiles and accessories, rental revenue from investment properties, marketing of the insurance products of life and general insurance companies.
The Company is diversifying into more fee based activities. The flagship of the once undivided Pai group, ICDS has now come under the fold of Mohandas Pai, with Ramesh Pai having transferred his share to the Mohandas Pai group in 1995, the silver jubilee year.
Over the past 25 years, the company has built a strong base.
Formed to succeed Syndicate Bank, after the latter's nationalisation, ICDS comes from very good stock.

About Indrayani Biotech Ltd

Indrayani Biotech Limited was incorporated in 1992.
The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds.
Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture.
The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California. IBL started exporting flowers to Holland and Dubai during 1994-95.

FAQs for the comparison of ICDS Ltd and Indrayani Biotech Ltd

Which company has a larger market capitalization, ICDS Ltd or Indrayani Biotech Ltd?

Market cap of ICDS Ltd is 59 Cr while Market cap of Indrayani Biotech Ltd is 55 Cr

What are the key factors driving the stock performance of ICDS Ltd and Indrayani Biotech Ltd?

The stock performance of ICDS Ltd and Indrayani Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ICDS Ltd and Indrayani Biotech Ltd?

As of April 21, 2026, the ICDS Ltd stock price is INR ₹45.35. On the other hand, Indrayani Biotech Ltd stock price is INR ₹12.08.

How do dividend payouts of ICDS Ltd and Indrayani Biotech Ltd compare?

To compare the dividend payouts of ICDS Ltd and Indrayani Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.